Forward Pharma A/S (FWPAY)
Forward Pharma A/S operates in the Biotechnology industry of the Healthcare sector, headquartered in Copenhagen, DK. The stock last traded at $300.00, down 25.09% on the session, giving a market capitalisation of $7.4M. On trailing twelve-month figures it carries a trailing P/E of -3.88, a net margin of 0.0%. Its beta of 1.02 implies it has historically moved more than the broad market.
Forward Pharma A/S presently engages in very limited business activities. In the past, this biopharmaceutical firm concentrated its efforts on developing FP187, its distinctive formulation of dimethyl fumarate, which was aimed at addressing both inflammatory and neurological conditions. The company was founded in 2005 and its headquarters are located in Copenhagen, Denmark.
Forward Pharma A/S is most often compared with the following Healthcare names: